Device Trial Radar · NCT06064071
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
Last checked: Nov 21, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 18, 2023
Primary completion
Sep 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Candela CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 3, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Clinical Study Evaluating Nordlys™ System with Selective Waveband Technology (SWT)® Intense Pulsed Light (IPL) Applicators for Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD).
Conditions
- Meibomian Gland Dysfunction
- Dry Eye Disease
Interventions
Nordlys SWT IPLDevice
Nordlys™ System with Selective Waveband Technology (SWT)® IPL Applicators
Meibomian Gland Expression (MGX)Procedure
Meibomian glands are squeezed (by applying force on the inner and outer surfaces of the eyelid with a specially designed forceps, Q-tips, or fingers) in order to unclog obstructed glands and evacuate their content (the meibum), which in MGD is often viscous and thus causing obstruction
Sham Nordlys SWT IPLDevice
Sham treatment with Nordlys™ System with Selective Waveband Technology (SWT)® IPL Applicators device turned off
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement of Tear Breakup Time (TBUT) from baseline to 4-week follow-upTime frame: Baseline, 4-Week Follow Up (Week 10)
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
Center for Excellence in Eye Care
Miami, Florida
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.